Vertex Pharmaceuticals(VRTX) · US
Sector: XLV | Last updated: 15 Oct 2026
Vertex Pharmaceuticals (VRTX) is showing Neutral momentum today, with an Altra Score of 57.9 on AltraOne's multi-timeframe (MTF) momentum analysis. The stock is part of the XLV sector, where it ranks 41 by relative strength in a currently neutral RS regime (Relative Strength: 298.62). Recent EMA crossover activity: Close above EMA 8. VRTX closed at 508.75 on 15 Oct 2026 (-1.20% for the day), based on end-of-day (EOD) price data rather than a live quote.
Price
Stock Relative Strength
Latest EMA CrossOvers
VRTX's Daily RSI(14) is 48.4 (up 6.4 from prior), Weekly RSI is 54.5 (down 0.4 from prior), and Monthly RSI is 58.7 (down 3.1 from prior). Price is currently trading above its Daily EMA 8, Daily EMA 200, Weekly EMA 30, but below its Daily EMA 20, Daily EMA 50, Weekly EMA 8.
Multi-Timeframe RSI (14)
| Timeframe | RSI | Prev | Change |
|---|---|---|---|
| Daily | 48.4 | 42.0 | ▲ 6.4 |
| Weekly | 54.5 | 54.9 | ▼ 0.4 |
| Monthly | 58.7 | 61.8 | ▼ 3.1 |
Stock Price and EMA Placement
History
TradingView ↗The current active signal for VRTX is Bullish, triggered on 22 Jun 2026 at a price of 466.79. Since then, the stock has gained 8.99%.
These are long-term momentum shifts, not buy/sell recommendations.